Angiography contrast medium injection system, line-powered, mobile
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
17-01-2022
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Intervene Medical Pty Ltd
Class:
Class IIb
Manufactured by:
Angiodroid SpA Via Speanza 35, San Lazzaro di Savana, BO, 40068 Italy
Therapeutic area:
57997 - Angiography contrast medium injection system, line-powered, mobile
Therapeutic indications:
The device allows the intravascular injection of CO2, with precise volume dose and injection pressure, to perform Automated Carbon Dioxide Angiography (ACDA). CO2 acts as a contrast agent in an angiographic examination.
Authorization status:
A
Authorization date:
2021-11-02
